Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 5 (2008), Issue 3 (March)

1. Diagnostic targeting of colon cancer using a novel fluorescent somatostatin conjugate in a mouse xenograft model.
   Int J Cancer, 122(9): 2044-9. [Abstract] [Full-text]
2. Apoptosis of estrogen-receptor negative breast cancer and colon cancer cell lines by PTP alpha and src RNAi.
   Int J Cancer, 122(9): 1999-2007. [Abstract] [Full-text]
3. The possible role of factor H in colon cancer resistance to complement attack.
   Int J Cancer, 122(9): 2030-7. [Abstract] [Full-text]
4. Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells.
   Int J Cancer, 122(9): 2115-24. [Abstract] [Full-text]
5. Identification of susceptibility genes for cancer in a genome-wide scan: results from the colon neoplasia sibling study.
   Am J Hum Genet, 82(3): 723-36. [Abstract] [Full-text]
6. Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology.
   J Gastroenterol Hepatol, 23(3): 418-23. [Abstract] [Full-text]
7. High folic acid increases cell turnover and lowers differentiation and iron content in human HT29 colon cancer cells.
   Br J Nutr, 99(4): 703-8. [Abstract] [Full-text]
8. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells.
   Oncogene, 27(11): 1527-35. [Abstract] [Full-text]
9. Quality of life and symptom attribution in long-term colon cancer survivors.
   J Eval Clin Pract, 14(2): 254-8. [Abstract] [Full-text]
10. Proteasomal degradation of Atoh1 by aberrant Wnt signaling maintains the undifferentiated state of colon cancer.
    Biochem Biophys Res Commun, 368(4): 923-9. [Abstract] [Full-text]
11. Comparison of outcomes of ileal pouch-anal anastomosis for familial adenomatous polyposis with and without previous ileorectal anastomosis.
    Br J Surg, 95(4): 494-8. [Abstract] [Full-text]
12. Detoxification enzyme polymorphisms are not involved in duodenal adenomatosis in familial adenomatous polyposis.
    Br J Surg, 95(4): 499-505. [Abstract] [Full-text]
13. Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer.
    Arch Intern Med, 168(5): 521-9. [Abstract] [Full-text]
14. Dacarbazine-Doxorubicin therapy ameliorated an extremely aggressive mesenteric desmoid tumor associated with familial adenomatous polyposis: report of a case.
    Jpn J Clin Oncol, 38(3): 222-6. [Abstract] [Full-text]
15. 1,1-bis(3'-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cells.
    Mol Carcinog, 47(4): 252-63. [Abstract] [Full-text]
16. Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity.
    Cancer Res, 68(6): 1962-9. [Abstract] [Full-text]
17. PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab.
    Cancer Res, 68(6): 1953-61. [Abstract] [Full-text]
18. Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells.
    Cancer Res, 68(6): 1732-40. [Abstract] [Full-text]
19. The prognostic significance of extracapsular lymph node involvement in node positive patients with colonic cancer.
    Eur J Surg Oncol, 34(4): 390-6. [Abstract] [Full-text]
20. Comparative lesion sequencing provides insights into tumor evolution.
    Proc Natl Acad Sci U S A, 105(11): 4283-8. [Abstract] [Full-text]
21. Specific imaging of VEGF-A expression with radiolabeled anti-VEGF monoclonal antibody.
    Int J Cancer, 122(10): 2310-4. [Abstract] [Full-text]
22. Designing antibodies for the inhibition of gastrin activity in tumoral cell lines.
    Int J Cancer, 122(10): 2351-9. [Abstract] [Full-text]
23. Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers.
    Int J Cancer, 122(10): 2255-9. [Abstract] [Full-text]
24. Anti-tumor activity of an anti-endoglin monoclonal antibody is enhanced in immunocompetent mice.
    Int J Cancer, 122(10): 2266-73. [Abstract] [Full-text]
25. Differences in patient postoperative and long-term outcomes between obstructive and perforated colonic cancer.
    Am J Surg, 195(4): 427-32. [Abstract] [Full-text]
26. IL-4/Stat6 activities correlate with apoptosis and metastasis in colon cancer cells.
    Biochem Biophys Res Commun, 369(2): 554-60. [Abstract] [Full-text]
27. Expression of cyclic guanosine monophosphate-dependent protein kinase in metastatic colon carcinoma cells blocks tumor angiogenesis.
    Cancer, 112(7): 1462-70. [Abstract] [Full-text]
28. Decreased CHK protein levels are associated with Src activation in colon cancer cells.
    Oncogene, 27(14): 2027-34. [Abstract] [Full-text]
29. Proteasome inhibition potentiates the cytotoxic effects of hyperthermia in HT-29 colon cancer cells through inhibition of heat shock protein 27.
    Oncology, 73(1): 98-103. [Abstract] [Full-text]
30. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
    Oncology, 73(1): 52-7. [Abstract] [Full-text]
31. Oestrogen and the colon: potential mechanisms for cancer prevention.
    Lancet Oncol, 9(4): 385-91. [Abstract] [Full-text]
32. HDAC2 deficiency sensitizes colon cancer cells to TNFalpha-induced apoptosis through inhibition of NF-kappaB activity.
    Exp Cell Res, 314(7): 1507-18. [Abstract] [Full-text]
33. A cancer-associated RING finger protein, RNF43, is a ubiquitin ligase that interacts with a nuclear protein, HAP95.
    Exp Cell Res, 314(7): 1519-28. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.